Zydus receives final approval from USFDA for Dasatinib Tablets
Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase
Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
Ibuprofen and famotidine combination is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis
No safety signals related to the vaccine candidate were identified
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
EMBLAVEOTM is the first and only monobactam/?-lactamase inhibitor combination antibiotic therapy approved by the USFDA
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
The company remains focused on strengthening its direct retail presence and expanding its reach to more customers across India.
Subscribe To Our Newsletter & Stay Updated